PT-141 serves as a cutting-edge cyclic melanocortin agonist that exhibits potential in the treatment of sexual dysfunction. This novel compound operates by activating specific receptors throughout the body, causing to augmented sexual function. Preclinical studies have indicated that PT-141 could effectively manage a variety of sexual dysfunctions